{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:47:47Z","timestamp":1750376867997,"version":"3.30.2"},"reference-count":209,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177053","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:21:18Z","timestamp":1728541278000},"page":"177053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Unveiling novel molecules and therapeutic targets in hypertension \u2013 A narrative review"],"prefix":"10.1016","volume":"984","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-5273","authenticated-orcid":false,"given":"Jefry","family":"Winner G","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7553-6852","authenticated-orcid":false,"given":"Surbhi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimpy","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177053_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.996755","article-title":"Antihypertensive potential of Brassica rapa leaves: an in vitro and in silico approach","volume":"13","author":"Abid","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177053_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-016-0346-0","article-title":"Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome","volume":"15","author":"Abu-Farha","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1747-0285.2008.00757.x","article-title":"The thermolysin family (M4) of enzymes: therapeutic and biotechnological potential","volume":"73","author":"Adekoya","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2024.177053_bib4","article-title":"Angiotensin-converting enzyme and hypertension: a systemic analysis of various ACE inhibitors, their side effects, and bioactive peptides as a putative therapy for hypertension","volume":"2023","author":"Ahmad","year":"2023","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.ejphar.2024.177053_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100130","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.ejphar.2024.177053_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2013.12.008","article-title":"Angiopoietin-1 regulates microvascular reactivity and protects the microcirculation during acute endothelial dysfunction: role of eNOS and VE-cadherin","volume":"80","author":"Alfieri","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"15","key":"10.1016\/j.ejphar.2024.177053_bib7","doi-asserted-by":"crossref","first-page":"15396","DOI":"10.1074\/jbc.M314291200","article-title":"Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration","volume":"279","author":"Allende","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.177053_bib8","unstructured":"Alnylam Pharmaceuticals. KARDIA: Zilebesiran Phase 2 Clinical Development Overview. \u201cKARDIA-1-Fact-Sheet.Pdf.\u201d2024 Accessed April 22, 2024. https:\/\/www.alnylam.com\/sites\/default\/files\/pdfs\/KARDIA-1-Fact-Sheet.pdf."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib9","first-page":"136","article-title":"Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension","volume":"9","author":"Ambrosino","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HJH.0b013e32800ff5d6","article-title":"A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity","volume":"25","author":"Amb\u00fchl","year":"2007","journal-title":"J. Hypertens."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177053_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/foods9080991","article-title":"In silico and in vitro analysis of multifunctionality of animal food-derived peptides","volume":"9","author":"Amigo","year":"2020","journal-title":"Foods"},{"issue":"8","key":"10.1016\/j.ejphar.2024.177053_bib12","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI67383","article-title":"Atrial natriuretic peptide is negatively regulated by microRNA-425","volume":"123","author":"Arora","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"8 Suppl. B","key":"10.1016\/j.ejphar.2024.177053_bib13","first-page":"9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J. Manag. Care Pharm."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cellsig.2014.03.022","article-title":"Heterodimerization of human apelin and bradykinin 1 receptors: novel signal transduction characteristics","volume":"26","author":"Bai","year":"2014","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4161\/hv.27520","article-title":"Hypertension Vaccine may be a boon to millions in developing world","volume":"10","author":"Bairwa","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.177053_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2003.10.011","article-title":"The regulation of aldosterone synthase expression","volume":"217","author":"Bassett","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/HYPERTENSIONAHA.109.130435","article-title":"Tetrahydrobiopterin, endothelial nitric oxide synthase, and mitochondrial function in the heart","volume":"53","author":"Bauersachs","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib19","first-page":"125","article-title":"Treatment-associated change in apelin concentration in patients with hypertension and its relationship with left ventricular diastolic function","volume":"17","author":"Baysal","year":"2017","journal-title":"Anatol. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib20","doi-asserted-by":"crossref","first-page":"H1031","DOI":"10.1152\/ajpheart.00899.2011","article-title":"How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension","volume":"302","author":"Blaustein","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"13","key":"10.1016\/j.ejphar.2024.177053_bib21","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-Phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.ejphar.2024.177053_bib22","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/pr.115.010652","article-title":"Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders","volume":"68","author":"Brozovich","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2024.177053_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fmicb.2015.00711","article-title":"MRJP1-containing glycoproteins isolated from honey, a novel antibacterial drug candidate with broad spectrum activity against multi-drug resistant clinical isolates","volume":"6","author":"Brudzynski","year":"2015","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.metabol.2016.06.002","article-title":"Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: the cardiovascular health study","volume":"65","author":"Brutsaert","year":"2016","journal-title":"Metabolism"},{"issue":"18","key":"10.1016\/j.ejphar.2024.177053_bib26","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ejphar.2024.177053_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189858","article-title":"A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"12","author":"Cannone","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejphar.2024.177053_bib28","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.3934","article-title":"Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure","volume":"21","author":"Cantalupo","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.117.09088","article-title":"S1PR1 (Sphingosine-1-Phosphate receptor 1) signaling regulates blood flow and pressure","volume":"70","author":"Cantalupo","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.177053_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.721733","article-title":"A critical review on phytochemical profile and biological effects of turnip (Brassica rapa L.)","volume":"8","author":"Cao","year":"2021","journal-title":"Front. Nutr."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mayocp.2012.02.003","article-title":"Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension","volume":"87","author":"Cataliotti","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2024.177053_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03662.x","article-title":"Mechanisms determining sensitivity of baroreceptor afferents in health and disease","volume":"940","author":"Chapleau","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"17","key":"10.1016\/j.ejphar.2024.177053_bib33","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/cvr\/cvad171","article-title":"Targeting the apelin system for the treatment of cardiovascular diseases","volume":"119","author":"Chapman","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177053_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006347","article-title":"Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway","volume":"6","author":"Chen","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib37","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/HYPERTENSIONAHA.122.18731","article-title":"Angiotensinogen suppression: a new tool to treat cardiovascular and renal disease","volume":"79","author":"Cruz-L\u00f3pez","year":"2022","journal-title":"Hypertension (Dallas)"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bph.15955","article-title":"Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes","volume":"180","author":"Cruz-L\u00f3pez","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177053_bib39","first-page":"1","article-title":"Novel angiotensin I-converting enzyme inhibitory peptides from soybean protein isolates fermented by Pediococcus pentosaceus SDL1409","volume":"43","author":"Daliri","year":"2018","journal-title":"J. Funct.Foods"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1755-5922.12053","article-title":"Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat","volume":"32","author":"Dalzell","year":"2014","journal-title":"Cardiovasc. Ther."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib41","doi-asserted-by":"crossref","first-page":"H1200","DOI":"10.1152\/ajpheart.00216.2018","article-title":"Regulation of sympathetic vasomotor activity by the hypothalamic paraventricular nucleus in normotensive and hypertensive states","volume":"315","author":"Dampney","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib42","doi-asserted-by":"crossref","first-page":"H2045","DOI":"10.1152\/ajpheart.01089.2002","article-title":"Sphingosine 1-phosphate and control of vascular tone","volume":"284","author":"Dantas","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177053_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104020","article-title":"Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production","volume":"9","author":"De Batista","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/HYPERTENSIONAHA.114.04492","article-title":"Bilateral or unilateral stimulation for baroreflex activation therapy","volume":"65","author":"de Leeuw","year":"2015","journal-title":"Hypertension (Dallas)"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA interference therapeutic agent for hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101918","article-title":"Baxdrostat: a novel aldosterone synthase inhibitor for treatment resistant hypertension","volume":"48","author":"Dogra","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177053_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/1060028020968808","article-title":"Osilodrostat: a novel steroidogenesis inhibitor to treat cushing\u2019s disease","volume":"55","author":"Dougherty","year":"2021","journal-title":"Ann. Pharmacother."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib48","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.CIR.85.5.1751","article-title":"Alterations of skeletal muscle in chronic heart failure","volume":"85","author":"Drexler","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177053_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172979","article-title":"Vasoactive intestinal peptide infusion reverses existing renal interstitial fibrosis via a blood pressure independent mechanism in the rat","volume":"873","author":"Duggan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/hv.5.10.9518","article-title":"Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years","volume":"5","author":"Einstein","year":"2009","journal-title":"Hum. Vaccine"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib51","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00165-2023","article-title":"Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs","volume":"62","author":"Ernest","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0192623314555162","article-title":"The future of preclinical animal models in pharmaceutical discovery and development: a need to bring in cerebro to the in vivo discussions","volume":"43","author":"Everitt","year":"2015","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0163-7258(89)90129-0","article-title":"VIP and autonomic neurotransmission","volume":"41","author":"Fahrenkrug","year":"1989","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2024.177053_bib54","article-title":"Functional and proteomic investigations reveal major royal jelly protein 1 associated with anti-hypertension activity in mouse vascular smooth muscle cells","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib55","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/ajh\/hpaa084","article-title":"Chemerin as a driver of hypertension: a consideration","volume":"33","author":"Ferland","year":"2020","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib56","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.foodchem.2007.04.063","article-title":"Chemical and antioxidative assessment of dietary turnip (Brassica rapa var. rapa L.)","volume":"105","author":"Fernandes","year":"2007","journal-title":"Food Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib58","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1523-1755.2004.66004.x","article-title":"AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction","volume":"66","author":"Fukami","year":"2004","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib59","doi-asserted-by":"crossref","first-page":"e2882","DOI":"10.1210\/clinem\/dgac178","article-title":"Randomized trial of osilodrostat for the treatment of cushing disease","volume":"107","author":"Gadelha","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acs.chemmater.2c03003","article-title":"The future of drug delivery","volume":"35","author":"Gao","year":"2023","journal-title":"Chem. Mater."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib61","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41440-021-00643-z","article-title":"Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies","volume":"44","author":"Ghatage","year":"2021","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2024.177053_bib62","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9692.1","article-title":"Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy","volume":"6","author":"Ghazi","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ejphar.2024.177053_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1058488","article-title":"Regulation by Nrf2 of IL-1\u03b2-induced inflammatory and oxidative response in VSMC and its relationship with TLR4","volume":"14","author":"Gonz\u00e1lez-Carnicero","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231844","article-title":"Increased apelin receptor gene expression in the subfornical organ of spontaneously hypertensive rats","volume":"15","author":"Griffiths","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001831","article-title":"Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study","volume":"4","author":"Gupta","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.1998.tb11158.x","article-title":"Cis-regulatory elements controlling basal and inducible VIP gene transcription","volume":"865","author":"Hahm","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib67","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1172\/JCI117605","article-title":"Gadolinium inhibits mechanoelectrical transduction in rabbit carotid baroreceptors. Implication of stretch-activated channels","volume":"94","author":"Hajduczok","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens. Res."},{"issue":"6070","key":"10.1016\/j.ejphar.2024.177053_bib69","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","article-title":"Crystal structure of a lipid G protein-coupled receptor","volume":"335","author":"Hanson","year":"2012","journal-title":"Science (New York, N.Y.)"},{"issue":"23\u201324","key":"10.1016\/j.ejphar.2024.177053_bib70","first-page":"831","article-title":"\u00dcber den Einfluss der Karotissinus-Reizung auf das Hirnstrombild","volume":"43","author":"Hauss","year":"1954","journal-title":"Z. Kreislaufforsch."},{"issue":"686","key":"10.1016\/j.ejphar.2024.177053_bib71","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.3399\/bjgp19X705077","article-title":"Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care","volume":"69","author":"Hayes","year":"2019","journal-title":"Br. J. Gen. Pract."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177053_bib72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/md21080422","article-title":"Generation of bioactive peptides from Porphyridium sp. and assessment of their potential for use in the prevention of hypertension, inflammation and pain","volume":"21","author":"Hayes","year":"2023","journal-title":"Mar. Drugs"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib73","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/ATVBAHA.118.311289","article-title":"Deficiency of FAM3D (family with sequence similarity 3, member D), A novel chemokine, attenuates neutrophil recruitment and ameliorates abdominal aortic aneurysm development","volume":"38","author":"He","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164179","article-title":"Signaling properties of chemerin receptors CMKLR1, GPR1 and CCRL2","volume":"11","author":"Henau","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","article-title":"Vasoactive intestinal peptide: cardiovascular effects","volume":"49","author":"Henning","year":"2001","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib76","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","article-title":"Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients","volume":"55","author":"Heusser","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.177053_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/20406223241239775","article-title":"Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis","volume":"15","author":"Ho","year":"2024","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/HYPERTENSIONAHA.115.05610","article-title":"B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival: novel model for human hypertension","volume":"66","author":"Holditch","year":"2015","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib79","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/pro.5560041001","article-title":"Structural analysis of zinc substitutions in the active site of thermolysin","volume":"4","author":"Holland","year":"1995","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib80","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0022-2836(82)90319-9","article-title":"Structure of thermolysin refined at 1.6 A resolution","volume":"160","author":"Holmes","year":"1982","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib81","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1111\/bcp.14825","article-title":"Hypertension: current trends and future perspectives","volume":"87","author":"Hunter","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib82","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/cvr\/cvp064","article-title":"Sphingosine-1-phosphate and modulation of vascular tone","volume":"82","author":"Igarashi","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.120.15006","article-title":"Serum aldosterone concentration, blood pressure, and coronary artery calcium: the multi-ethnic study of atherosclerosis","volume":"76","author":"Inoue","year":"2020","journal-title":"Hypertension (Dallas)"},{"issue":"1 Pt C","key":"10.1016\/j.ejphar.2024.177053_bib84","article-title":"Hypertension and lorundrostat: key discoveries from the TARGET-HTN trial","volume":"49","author":"Irfan","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib85","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089201","article-title":"Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study","volume":"9","author":"Juji\u0107","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib87","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.devcel.2012.07.015","article-title":"Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development","volume":"23","author":"Jung","year":"2012","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/picr.PICR_147_16","article-title":"Informed consent process: a step further towards making it meaningful","volume":"8","author":"Kadam","year":"2017","journal-title":"Perspect. Clin. Res."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2024.177053_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.regpep.2004.07.033","article-title":"Central and peripheral cardiovascular actions of apelin in conscious rats","volume":"125","author":"Kagiyama","year":"2005","journal-title":"Regul. Pept."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib90","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCULATIONAHA.121.057687","article-title":"Clinical trial design principles and outcomes definitions for device-based therapies for hypertension: a consensus document from the hypertension academic research consortium","volume":"145","author":"Kandzari","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/ar3475","article-title":"Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis","volume":"13","author":"Kaneko","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib92","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cvr\/cvp073","article-title":"Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension","volume":"82","author":"Kang","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib93","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/CIRCRESAHA.113.301324","article-title":"Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development","volume":"113","author":"Kang","year":"2013","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib94","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","article-title":"Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study","volume":"107","author":"Kario","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib95","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1177\/1535370215587533","article-title":"Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats","volume":"240","author":"Kasacka","year":"2015","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib96","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1152\/japplphysiol.00161.2018","article-title":"High-intensity muscle metaboreflex activation attenuates cardiopulmonary baroreflex-mediated inhibition of muscle sympathetic nerve activity","volume":"125","author":"Katayama","year":"2018","journal-title":"J. Appl. Physiol."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib97","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004421","article-title":"Chemerin elicits potent constrictor actions via chemokine-like receptor 1 (CMKLR1), not G-protein-coupled receptor 1 (GPR1), in human and rat vasculature","volume":"5","author":"Kennedy","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/hh1801.097034","article-title":"Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression","volume":"89","author":"Kim","year":"2001","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177053_bib99","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1172\/JCI84871","article-title":"Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/HYPERTENSIONAHA.118.12352","article-title":"Podocyte injury augments intrarenal angiotensin II generation and sodium retention in a megalin-dependent manner","volume":"74","author":"Koizumi","year":"2019","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ejphar.2024.177053_bib101","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1172\/JCI84923","article-title":"Tie1 controls angiopoietin function in vascular remodeling and inflammation","volume":"126","author":"Korhonen","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.177053_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2261-14-56","article-title":"Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?","volume":"14","author":"Kostopoulos","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ejphar.2024.177053_bib103","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2024.177053_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4109874","article-title":"A revolutionary blueprint for mitigation of hypertension via nanoemulsion","volume":"2022","author":"Kumar","year":"2022","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2024.177053_bib105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.foodchem.2013.11.143","article-title":"Identification of peptides from soybean protein, glycinin, possessing suppression of intracellular Ca2+ concentration in vascular smooth muscle cells","volume":"152","author":"Kumrungsee","year":"2014","journal-title":"Food Chem."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177053_bib106","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: the target-HTN randomized clinical trial","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib108","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/molecules26020386","article-title":"Theoretical evaluation of novel thermolysin inhibitors from Bacillus thermoproteolyticus. Possible antibacterial agents","volume":"26","author":"Lamazares","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib109","first-page":"61","article-title":"Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward","volume":"17","author":"Largent","year":"2017","journal-title":"Yale J. Health Pol. Law Ethics"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib111","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1096\/fj.03-1466com","article-title":"Biological characterization of angiopoietin-3 and angiopoietin-4","volume":"18","author":"Lee","year":"2004","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib112","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/cvr\/cvn048","article-title":"Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor","volume":"78","author":"Lee","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.177053_bib114","article-title":"Central blockade of salusin \u03b2 attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2024.177053_bib113","first-page":"275","article-title":"Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats","volume":"16","author":"Li","year":"2007","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib116","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1073\/pnas.84.2.605","article-title":"Structure and expression of the gene encoding the vasoactive intestinal peptide precursor","volume":"84","author":"Linder","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2024.177053_bib117","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.lfs.2012.04.013","article-title":"The adipokine chemerin augments vascular reactivity to contractile stimuli via activation of the MEK\u2010ERK1\/2 pathway","volume":"91","author":"Lobato","year":"2012","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib118","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/hr.2016.17","article-title":"Structure and functions of angiotensinogen","volume":"39","author":"Lu","year":"2016","journal-title":"Hypertens. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib119","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jsps.2020.03.010","article-title":"Evaluation of new antihypertensive drugs designed in silico using Thermolysin as a target","volume":"28","author":"MacLeod-Carey","year":"2020","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ejphar.2024.177053_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106030","article-title":"Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury","volume":"175","author":"Majumder","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.RES.43.2.170","article-title":"Baroreceptor reflexes in human hypertension","volume":"43","author":"Mancia","year":"1978","journal-title":"Circ. Res."},{"issue":"6972","key":"10.1016\/j.ejphar.2024.177053_bib122","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2024.177053_bib123","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-4889(03)00043-0","article-title":"Recycling of vitamin C from its oxidized forms by human endothelial cells","volume":"1640","author":"May","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib124","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacbts.2016.10.001","article-title":"Innovative therapeutics: designer natriuretic peptides","volume":"1","author":"Meems","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.ejphar.2024.177053_bib126","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2277-9175.213877","article-title":"Association of animal and plant proteins intake with hypertension in Iranian adult population: isfahan healthy heart program","volume":"6","author":"Mehrabani","year":"2017","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ejphar.2024.177053_bib127","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6668919","article-title":"Antihypertensive effects of the vitex cienkowskii (verbenaceae) stem-bark extract on L-NAME-induced hypertensive rats","volume":"2021","author":"Metchi Donfack","year":"2021","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.ejphar.2024.177053_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107799","article-title":"Role of inflammatory chemokines in hypertension","volume":"223","author":"Mikolajczyk","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177053_bib129","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/014107680409701205","article-title":"Sham procedures and the ethics of clinical trials","volume":"97","author":"Miller","year":"2004","journal-title":"J. R. Soc. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib131","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.34059","article-title":"A method to quantify mean hypertension treatment daily dose intensity using health care system data","volume":"4","author":"Min","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"26","key":"10.1016\/j.ejphar.2024.177053_bib132","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1016\/S0021-9258(18)55404-1","article-title":"Vasoactive intestinal peptide, a singlet oxygen quencher","volume":"265","author":"Misra","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib133","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41440-021-00790-3","article-title":"Clinical study on angiotensin II vaccination\u2014the first big step","volume":"45","author":"Mogi","year":"2022","journal-title":"Hypertens. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib134","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacbts.2021.04.004","article-title":"Antisense inhibition of angiotensinogen with IONIS-AGT-LRx: results of phase 1 and phase 2 studies","volume":"6","author":"Morgan","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.118.248682","article-title":"Activation of large conductance, calcium-activated potassium channels by nitric oxide mediates apelin-induced relaxation of isolated rat coronary arteries","volume":"366","author":"Mughal","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib136","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.117.09755","article-title":"Blood pressure lowering and safety improvements with liver angiotensinogen inhibition in models of hypertension and kidney injury","volume":"70","author":"Mullick","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060493","article-title":"Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice","volume":"8","author":"Nakagami","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib138","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13237-022-00405-3","article-title":"Plant-derived natural products for drug discovery: current approaches and prospects","volume":"65","author":"Nasim","year":"2022","journal-title":"Nucleus"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib139","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.328","article-title":"Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat. Genet."},{"issue":"11 Pt 1","key":"10.1016\/j.ejphar.2024.177053_bib140","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2024.177053_bib141","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jff.2015.06.021","article-title":"The scientific evidence for the role of milk protein-derived bioactive peptides in humans: a Review","volume":"17","author":"Nongonierma","year":"2015","journal-title":"J. Funct.Foods"},{"issue":"7305","key":"10.1016\/j.ejphar.2024.177053_bib142","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.323.7305.142","article-title":"Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study","volume":"323","author":"Nuesch","year":"2001","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ejphar.2024.177053_bib143","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0196-9781(98)00102-8","article-title":"Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis","volume":"19","author":"Nussdorfer","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2024.177053_bib144","article-title":"Exploring the impact of ACE inhibition in immunity and disease","volume":"2022","author":"Oosthuizen","year":"2022","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.ejphar.2024.177053_bib145","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib146","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.3390\/ijms24065370","article-title":"The effect of aldosterone on cardiorenal and metabolic systems","volume":"24","author":"Otsuka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib147","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3892\/ijmm.2014.1829","article-title":"Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure","volume":"34","author":"Pang","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"13","key":"10.1016\/j.ejphar.2024.177053_bib148","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1074\/jbc.275.13.9102","article-title":"Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt\/survivin pathway","volume":"275","author":"Papapetropoulos","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib149","first-page":"229","article-title":"Adherence to antihypertensive therapy","volume":"101","author":"Peacock","year":"2017","journal-title":"Med. Clin."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177053_bib150","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1242\/jcs.183053","article-title":"Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors","volume":"129","author":"Peng","year":"2016","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib151","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.peptides.2011.12.005","article-title":"Central and peripheral apelin receptor distribution in the mouse: species differences with rat","volume":"33","author":"Pope","year":"2012","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib152","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ar.23829","article-title":"The carotid sinus nerve-structure, function, and clinical implications","volume":"302","author":"Porzionato","year":"2019","journal-title":"Anat. Rec. Hoboken"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib153","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00421-018-3831-1","article-title":"The influence of the carotid baroreflex on dynamic regulation of cerebral blood flow and cerebral tissue oxygenation in humans at rest and during exercise","volume":"118","author":"Purkayastha","year":"2018","journal-title":"Eur. J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib154","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1038\/s41598-017-06484-6","article-title":"Toll-like receptor 4 deficiency reduces oxidative stress and macrophage mediated inflammation in hypertensive kidney","volume":"7","author":"Pushpakumar","year":"2017","journal-title":"Sci. Rep."},{"issue":"48","key":"10.1016\/j.ejphar.2024.177053_bib155","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical angiopoietin-like protein that regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib156","first-page":"1","article-title":"Drug delivery to the lymphatic system: the road less travelled","volume":"14","author":"Rama","year":"2024","journal-title":"J. Appl. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib157","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.RES.26.4.461","article-title":"Measurement of arterial geometry and wall composition in the carotid sinus baroreceptor area","volume":"26","author":"Rees","year":"1970","journal-title":"Circ. Res."},{"issue":"99","key":"10.1016\/j.ejphar.2024.177053_bib158","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","author":"Remuzzi","year":"2005","journal-title":"Kidney Int. Suppl."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib159","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00238309","article-title":"Immunocytochemical localization of angiotensinogen in rat liver and kidney","volume":"233","author":"Richoux","year":"1983","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","article-title":"Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL","volume":"39","author":"Romeo","year":"2007","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01735-z","article-title":"Apelin expression deficiency in mice contributes to vascular stiffening by extracellular matrix remodeling of the aortic wall","volume":"11","author":"Romier","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib162","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0008-6363(96)00202-7","article-title":"Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs","volume":"33","author":"Roossien","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.177053_bib163","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2015.09.002","article-title":"CMKLR1 and GPR1 mediate chemerin signaling through the RhoA\/ROCK pathway","volume":"417","author":"Rourke","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib164","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.108.111211","article-title":"Aldosterone, hypertension, and cardiovascular disease: an endless story","volume":"52","author":"Ruilope","year":"2008","journal-title":"Hypertension"},{"issue":"9722","key":"10.1016\/j.ejphar.2024.177053_bib165","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib166","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ncb1715","article-title":"Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts","volume":"10","author":"Saharinen","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib167","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/nano6010017","article-title":"Excipient nanoemulsions for improving oral bioavailability of bioactives","volume":"6","author":"Salvia-Trujillo","year":"2016","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib168","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jch.13449","article-title":"The impact of apelin and relaxin plasma levels in masked hypertension and white coat hypertension","volume":"21","author":"Sanidas","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ejphar.2024.177053_bib169","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fendo.2014.00004","article-title":"Angiopoietin-like proteins: a comprehensive look","volume":"5","author":"Santulli","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib170","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.celrep.2015.08.024","article-title":"The orphan receptor Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells","volume":"12","author":"Savant","year":"2015","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib171","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1476-5381.2011.01260.x","article-title":"Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system","volume":"163","author":"Schuchardt","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib172","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1017\/cts.2022.423","article-title":"Improving quality and efficiency of translational research: environmental scan of adaptive capacity and preparedness of Clinical and Translational Science Award Program hubs","volume":"7","author":"Shah","year":"2022","journal-title":"J. Clin. Transl. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib173","article-title":"Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension","volume":"4","author":"Shen","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700732","article-title":"A novel antihypertensive peptide identified in thermolysin-digested rice bran","volume":"62","author":"Shobako","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2024.177053_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.645123","article-title":"Angiotensinogen and the modulation of blood pressure","volume":"8","author":"Shu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib177","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib178","first-page":"155","article-title":"Chronomodulated drug delivery systems for the treatment of hypertension: an overview","volume":"2","author":"Sivaneswari","year":"2024","journal-title":"Int. Pharmacop."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib179","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.HYP.0000101688.17370.87","article-title":"Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren","volume":"42","author":"Stanton","year":"2003","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12020-013-0003-2","article-title":"Circulating chemerin decreases in response to a combined strength and endurance training","volume":"45","author":"Stefanov","year":"2014","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib181","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5507\/bp.2008.033","article-title":"Chemerin is an independent marker of the metabolic syndrome in a Caucasian population\u2014a pilot study","volume":"152","author":"Stejskal","year":"2008","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc"},{"key":"10.1016\/j.ejphar.2024.177053_bib182","article-title":"Renin-angiotensin system acting on reactive oxygen species in paraventricular nucleus induces sympathetic activation via AT1R\/PKC\u03b3\/Rac1 pathway in salt-induced hypertension","volume":"7","author":"Su","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib183","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/antiox11020288","article-title":"Na+\/K+-ATPase alpha 2 isoform elicits Rac1-dependent oxidative stress and TLR4-induced inflammation in the hypothalamic paraventricular nucleus in high salt-induced hypertension","volume":"11","author":"Su","year":"2022","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib184","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/ALN.0000000000002510","article-title":"Contribution of baroreceptor function to pain perception and perioperative outcomes","volume":"130","author":"Suarez-Roca","year":"2019","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177053_bib185","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4070\/kcj.2011.41.10.590","article-title":"Angiopoietin-1 gene therapy attenuates hypertension and target organ damage in nitric oxide synthase inhibited spontaneously hypertensive rats","volume":"41","author":"Suh","year":"2011","journal-title":"Korean Circ. J."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib186","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228265","article-title":"In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1","volume":"15","author":"Tahir","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib188","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.atherosclerosis.2015.05.018","article-title":"Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice","volume":"241","author":"Theelen","year":"2015","journal-title":"Atherosclerosis"},{"issue":"9615","key":"10.1016\/j.ejphar.2024.177053_bib189","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","article-title":"Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study","volume":"371","author":"Tissot","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrendo.2009.263","article-title":"Aldosterone and arterial hypertension","volume":"6","author":"Tomaschitz","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib191","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular smooth muscle contraction in hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.177053_bib192","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.wneu.2019.01.096","article-title":"Surgical treatment of spontaneous internal carotid artery dissection with abducent nerve palsy: case report and review of literature","volume":"125","author":"Tsuboki","year":"2019","journal-title":"World Neurosurg."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177053_bib193","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/HYPERTENSIONAHA.119.12703","article-title":"Strong and sustained antihypertensive effect of small interfering RNA targeting liver angiotensinogen","volume":"73","author":"Uijl","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib194","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbapap.2011.03.009","article-title":"Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments","volume":"1814","author":"Umetsu","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11906-018-0840-8","article-title":"Endovascular baroreflex amplification for resistant hypertension","volume":"20","author":"Van Kleef","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177053_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259826","article-title":"Endovascular baroreflex amplification and the effect on sympathetic nerve activity in patients with resistant hypertension: a proof-of-principle study","volume":"16","author":"Van Kleef","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177053_bib197","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacbts.2020.03.010","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: Part 2: potential alternatives to the use of animals in preclinical trials","volume":"5","author":"Van Norman","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.ejphar.2024.177053_bib198","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3389\/fpsyg.2017.01687","article-title":"Older adults perceptions of technology and barriers to interacting with tablet computers: a focus group study","volume":"8","author":"Vaportzis","year":"2017","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib199","first-page":"206","article-title":"Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants","volume":"11","author":"Vasdev","year":"2006","journal-title":"Exp. Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0031-1278316","article-title":"The antihypertensive effect of cysteine","volume":"18","author":"Vasdev","year":"2009","journal-title":"Int. J. Angiol."},{"issue":"48","key":"10.1016\/j.ejphar.2024.177053_bib201","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/eurheartj\/ehu314","article-title":"Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure","volume":"35","author":"Vodovar","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2024.177053_bib202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygcen.2007.04.018","article-title":"Vasoactive intestinal peptide and the mammalian circadian system","volume":"152","author":"Vosko","year":"2007","journal-title":"Gen. Comp. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177053_bib203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1139\/bcb-2016-0073","article-title":"Research and development on lactoferrin and its derivatives in China from 2011-2015","volume":"95","author":"Wang","year":"2017","journal-title":"Biochem. Cell. Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177053_bib204","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ajh\/hpy074","article-title":"Blockade of TLR4 within the paraventricular nucleus attenuates blood pressure by regulating ROS and inflammatory cytokines in prehypertensive rats","volume":"31","author":"Wang","year":"2018","journal-title":"Am. J. Hypertens."},{"issue":"33","key":"10.1016\/j.ejphar.2024.177053_bib205","doi-asserted-by":"crossref","first-page":"12462","DOI":"10.1021\/acs.jafc.2c09148","article-title":"Identification and in silico analysis of ACE-inhibitory peptides derived from milk fermented by lacticaseibacillus paracasei","volume":"71","author":"Wang","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177053_bib206","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0b013e328360c200","article-title":"Evolving research in nongenomic actions of aldosterone","volume":"20","author":"Williams","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"15","key":"10.1016\/j.ejphar.2024.177053_bib207","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2174\/1568026617666161116143440","article-title":"Bioinformatics and drug discovery","volume":"17","author":"Xia","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"6 Pt 2","key":"10.1016\/j.ejphar.2024.177053_bib208","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.19.6.692","article-title":"In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats","volume":"19","author":"Yamamoto","year":"1992","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177053_bib209","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2310\/JIM.0b013e3181ec5db2","article-title":"Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension","volume":"58","author":"Yang","year":"2010","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.ejphar.2024.177053_bib210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2017.00092","article-title":"[Pyr1]Apelin-13(1-12) is a biologically active ACE2 metabolite of the endogenous cardiovascular peptide [Pyr1]Apelin-13","volume":"11","author":"Yang","year":"2017","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177053_bib211","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1152\/ajpregu.00323.2011","article-title":"Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice","volume":"302","author":"Yiannikouris","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.177053_bib212","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autneu.2009.03.005","article-title":"Role of supraspinal vasopressin neurones in the effects of atrial natriuretic peptide on sympathetic nerve activity","volume":"148","author":"Yusof","year":"2009","journal-title":"Auton. Neurosci. Basic Clin."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177053_bib213","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/aps.2013.198","article-title":"Chemerin C9 peptide induces receptor internalization through a clathrin-independent pathway","volume":"35","author":"Zhou","year":"2014","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400743X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400743X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:03:44Z","timestamp":1734570224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992400743X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":209,"alternative-id":["S001429992400743X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177053","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling novel molecules and therapeutic targets in hypertension \u2013 A narrative review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177053"}}